Rigenerand

Rigenerand srl (RR) is a start-up company spinning out from the University of Modena & Reggio Emilia (Modena,Italy). RR is a SME representing a unique enterprise, conjugating cGMP-grade cell manufacturing for cells and gene therapies with the design and development of avant-garde biomedical devices.

In the BOW project, RR will empower this expertise. WP1: i) Isolation, large scale expansion, characterization of human Endometrial Decidual Tissue derived MSC (EDT-MSC) to be use as EV producer cell line; ii) Development of a bioreactor platform to support the ex vivo expansion of EDT-MSC and to provide an increased yield of EVs.

Team

Olivia Candini

Head of R&D | Development of a GMP manufacturing process for the production of “immune-ghost” EVs derived from Endometrial Decidual Tissue Mesenchymal Stromal/Stem Cells (EDT-MSC)

Massimo Dominici

Scientific Founder | Development of a GMP manufacturing process for the production of “immune-ghost” EVs derived from Endometrial Decidual Tissue Mesenchymal Stromal/Stem Cells (EDT-MSC)

Laura Fiammenghi

Qualified Person – Cell factory | Development of a GMP manufacturing process for the production of “immune-ghost” EVs derived from Endometrial Decidual Tissue Mesenchymal Stromal/Stem Cells (EDT-MSC)

Stella Frabetti

R&D Scientist | Development of a GMP manufacturing process for the production of “immune-ghost” EVs derived from Endometrial Decidual Tissue Mesenchymal Stromal/Stem Cells (EDT-MSC)

Simona Guidi

Business Development Director | Development of a GMP manufacturing process for the production of “immune-ghost” EVs derived from Endometrial Decidual Tissue Mesenchymal Stromal/Stem Cells (EDT-MSC)